Triple-Negative Breast Cancer (TNBC) is clinically defined by the lack of expression of the estrogen (ER) and progesterone (PgR) receptor genes, and by the absence of amplification of human epidermal growth factor receptor-2 (HER2). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.